Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor | Caris Life Sciences
Home / Research / Publications / Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor

Publications

Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor

Background

Desmoplastic Small Round Blue Cell Tumor (DSRCT) originates from a cell with multilineage potential. A molecular hallmark of DSCRT is the EWS-WT1 reciprocal translocation. Ewing’s and DSRCT
are treated similarly due to similar oncogene activation pathways and DSRCT has been represented in very limited numbers in sarcoma studies.

Download Publication
Learn More
Name(Required)